Statutory health insurance warns of a 23 billion euro shortfall – higher contributions are looming
,regionOfInterest=(320,180)&hash=1523da31a34c2bccd695f378533276408a474669be733c6e009f58667e3e2d2c)
Germany’s statutory health insurance system (*gesetzliche Krankenversicherung*, or public health insurance) is facing a severe financial crisis, with insurers warning that the funding shortfall could reach nearly €23 billion. This growing gap may lead to higher contribution rates for millions of insured citizens.
The *GKV-Spitzenverband* (National Association of Statutory Health Insurance Funds) has raised concerns over rapidly increasing healthcare costs and is urging the federal government to strengthen its planned austerity measures. According to the association’s CEO, Oliver Blatt, the current savings package is not enough to stabilize the system.
New financial data from the first quarter of 2026 shows healthcare spending rising much faster than expected. Overall benefit expenditures increased by 8% between January and March, reflecting what the association describes as an almost unstoppable rise in spending. Hospital treatment costs jumped by 9.4%, pharmaceutical expenses rose by 6.4%, and medical treatment costs increased by 7.3%.
Federal Health Minister Nina Warken currently estimates the statutory health insurance funding gap will reach €18.8 billion in 2027. However, the government’s proposed legislation covers only €16.3 billion, already leaving a gap of around €2.5 billion. The *GKV-Spitzenverband* warns the situation could worsen further because planned reserve-building measures for 2026 may fail, pushing the shortfall up by another €3–4 billion.
Health insurers are also criticizing the government’s financial strategy. Starting in 2027, federal contributions for *versicherungsfremde Leistungen* (non-insurance-related benefits), such as maternity pay and child sickness benefits, are expected to be reduced from €14.5 billion to €12.5 billion. Insurers argue this effectively shifts the burden onto contributors, meaning workers and employers may end up paying more.
The association is demanding changes to the planned contribution stabilization law and insists both the federal government and the pharmaceutical industry should contribute more to closing the funding gap. It also criticized tax advantages granted to pharmaceutical companies, arguing that industries benefiting from the healthcare sector should help carry the financial burden.
Although Minister Warken has promised to increase the law’s savings target to prevent contribution hikes, insurers say the latest expenditure figures show the urgency has become even greater. Without stronger intervention, millions of people could soon face significantly higher health insurance payments.